The biobank at the Colorado Center for Personalized Medicine (CCPM), a partnership between UC Health and the University of Colorado Anschutz Medical Campus, uses genetic data to identify specific genetic variants that could increase the risk of health problems, such as cancer or heart disease, as well as issues with how patients process a variety of medications.

A patient’s biobank results give them the opportunity to work with their providers to learn about their risks, make lifestyle changes to aid in prevention, and stay up to date about medical options for the best health outcomes. Pam Dyer, one of more than 227,000 patients who have consented to provide a blood sample in the biobank, learned about the gene TTR, which can cause hereditary transthyretin (ATTR) amyloidosis.

Read the full article on the UC Health website.